In the News

Experts from Stoke are consulted for input to inform news coverage about our innovative science, the serious diseases we are working to address, and the industry we are proud to be a part of.

STAT News  |  Apr 18, 2023

Gene Therapy for Duchenne Nears Historic Decision

Edward M. Kaye, M.D. discussed his contributions to the development of a gene therapy for Duchenne muscular dystrophy with STAT News.

LinkedIn  |  Mar 3, 2023

Perspective: Innovative medicines require innovative pathways to approval

Stoke CEO and Director Ed Kaye shared his thoughts about the March 2023 FDA approval of omaveloxolone, the first medicine to treat Friedreich’s Ataxia, and what is means for the rare disease community.

CheckRare  |  Sep 7, 2022

What is Dravet Syndrome?

Learn more from Stoke CMO Dr. Barry Ticho about the impact of #Dravetsyndrome on people living with the disease & the need for a medicine that treats the underlying cause in this CheckRare interview.

PharmaVoice  |  Sep 6, 2022

Most Inspiring People in the Life Sciences

Stoke CEO Edward M. Kaye, M.D. has been recognized by PharmaVoice as one of the 100 Most Inspiring People in the Life Sciences.

Endpoints  |  Jun 21, 2022

Leaders Giving Voice and Visibility to the LGBTQ Community

Isabel Aznarez was recognized among “15 Leaders Giving a Voice and Visibility to the LGBTQ Community in Biopharma,” in an article published by Endpoints in June 2022.

GEN  |  Jun 3, 2022

Dr. Nash and TANGO Featured in GEN

Genetic Engineering & Biotechnology News published an article about the history of and recent interest in mRNA-based medications, based in part on an interview with Stoke’s Chief Operating and Business Officer, Huw M. Nash, Ph.D.

BBJ  |  Jun 1, 2022

Coming Out Was a Necessary Step

The Boston Business Journal recognized Stoke’s co-founder Isabel Aznarez, Ph.D. as an LGBT Trailblazer for her contributions to ensure equity and inclusion at work and in the community. The awards were presented at the BBJ’s Business of Pride event in Boston on June 1, 2022.

STAT  |  Feb 28, 2022

Perspective in STAT’s Opinions+

Ed Kaye wrote this article for STAT in response to a decline in biotech stock indices, looking to the past for context, and to the future as a source of optimism.

Biotech2050  |  Dec 9, 2021

Biotech 2050 Podcast

Stoke’s Chief Medical Officer, Barry Ticho MD, PhD, shared his background in science and medical training on the Biotech2050 podcast. His unique experiences provide him with the necessary knowledge to help lead our team as we work to help people living with severe diseases.

FierceBiotech  |  Dec 7, 2021

Being openly LGBTQ+ in a scientist-led industry

Check out this FierceBiotech article featuring Isabel Aznarez, co-founder and VP, Head of Discovery Research, and other LGBTQ+ industry leaders working to encourage representation and inclusion in the workplace. They remind us to be ourselves and be proud of who we are.

BioSpace  |  Aug 5, 2021

Interview with BioSpace

CEO Edward Kaye spoke with BioSpace reporter Gail Dutton about the RNA Renaissance and potential for Stoke to take it in a new direction by upregulating protein expression.

Endpoints  |  May 19, 2021

Endpoints News’ 60 Over 60

In 2021, Ed Kaye was named in Endpoints News’ Legacies, a special feature highlighting 60 biopharma pioneers over 60 who helped birth a tech revolution in the making.

LinkedIn  |  Dec 30, 2020

Stoked and Grateful

Stoke’s co-founder Isabel Aznarez reflects on the many things she’s grateful for – doing what she loves, surrounded by colleagues she respects, and who are 100% committed to advancing science that may help people living with severe genetic diseases.

BeLatina  |  Jul 18, 2019

Powered by Latinas: the Tech Giants You Need to Know

These Latina founders are changing the landscape of the tech world and breaking funding records, all while using personal experience, grit, and community to reach their dreams while impacting the world.